| Descriptor English: | Mucopolysaccharidosis II | ||||||
| Descriptor Spanish: |
Mucopolisacaridosis II
| ||||||
| Descriptor Portuguese: | Mucopolissacaridose II | ||||||
| Descriptor French: | Mucopolysaccharidose de type II | ||||||
| Entry term(s): |
Deficiency, I2S Deficiency, Iduronate 2-Sulfatase Deficiency, Iduronate Sulfatase Deficiency, Sulfoiduronate Sulfatase Gargoylism, Hunter Syndrome Hunter Syndrome Hunter Syndrome Gargoylism Hunter's Syndrome Hunters Syndrome I2S Deficiency Iduronate 2 Sulfatase Deficiency Iduronate 2-Sulfatase Deficiency Iduronate Sulfatase Deficiency Mucopolysaccharidosis 2 Mucopolysaccharidosis Type 2 Mucopolysaccharidosis Type II Sulfoiduronate Sulfatase Deficiency Syndrome, Hunter Syndrome, Hunter's |
||||||
| Tree number(s): |
C10.597.606.360.455.750 C16.320.322.500.750 C16.320.400.525.750 C16.320.565.202.715.645 C16.320.565.595.600.645 C17.300.550.575.645 C18.452.648.202.715.645 C18.452.648.595.600.645 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D016532 | ||||||
| Scope note: | Systemic lysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of L-sulfoiduronate sulfatase. This disease differs from MUCOPOLYSACCHARIDOSIS I by slower progression, lack of corneal clouding, and X-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15. |
||||||
| Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||||
| Previous Indexing: |
Mucopolysaccharidosis I (1966-1991) |
||||||
| Public MeSH Note: | 1992; for MUCOPOLYSACCHARIDOSIS 2 and HUNTER'S SYNDROME see LIPOCHONDRODYSTROPHY 1976-1991 |
||||||
| History Note: | 1992; for MUCOPOLYSACCHARIDOSIS 2 and HUNTER'S SYNDROME use LIPOCHONDRODYSTROPHY 1976-1991 |
||||||
| Entry Version: | MPS II |
||||||
| Related: |
Iduronate Sulfatase
MeSH Mucopolysaccharidosis I MeSH | ||||||
| DeCS ID: | 29956 | ||||||
| Unique ID: | D016532 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1992/01/01 | ||||||
| Date of Entry: | 1991/06/21 | ||||||
| Revision Date: | 2018/07/01 |
|
|
Mucopolysaccharidosis II
- Preferred
Sulfoiduronate Sulfatase Deficiency
- Related but not broader or narrower
| Concept UI |
M0025232 |
| Scope note | Systemic lysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of L-sulfoiduronate sulfatase. This disease differs from MUCOPOLYSACCHARIDOSIS I by slower progression, lack of corneal clouding, and X-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15. |
| Preferred term | Mucopolysaccharidosis II |
| Entry term(s) |
Gargoylism, Hunter Syndrome Hunter Syndrome Hunter Syndrome Gargoylism Hunter's Syndrome Hunters Syndrome Mucopolysaccharidosis 2 Mucopolysaccharidosis Type 2 Mucopolysaccharidosis Type II Syndrome, Hunter Syndrome, Hunter's |
| Concept UI |
M0536361 |
| Preferred term | Sulfoiduronate Sulfatase Deficiency |
| Entry term(s) |
Deficiency, I2S Deficiency, Iduronate 2-Sulfatase Deficiency, Iduronate Sulfatase Deficiency, Sulfoiduronate Sulfatase I2S Deficiency Iduronate 2 Sulfatase Deficiency Iduronate 2-Sulfatase Deficiency Iduronate Sulfatase Deficiency |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
